AU2002356763A1 - Use of a technically modified cell as a vaccine for treating tumoral disease - Google Patents
Use of a technically modified cell as a vaccine for treating tumoral diseaseInfo
- Publication number
- AU2002356763A1 AU2002356763A1 AU2002356763A AU2002356763A AU2002356763A1 AU 2002356763 A1 AU2002356763 A1 AU 2002356763A1 AU 2002356763 A AU2002356763 A AU 2002356763A AU 2002356763 A AU2002356763 A AU 2002356763A AU 2002356763 A1 AU2002356763 A1 AU 2002356763A1
- Authority
- AU
- Australia
- Prior art keywords
- vaccine
- modified cell
- technically modified
- tumoral disease
- treating tumoral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000001173 tumoral effect Effects 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001148—Regulators of development
- A61K39/00115—Apoptosis related proteins, e.g. survivin or livin
- A61K39/001151—Apoptosis related proteins, e.g. survivin or livin p53
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/00118—Cancer antigens from embryonic or fetal origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001184—Cancer testis antigens, e.g. SSX, BAGE, GAGE or SAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001184—Cancer testis antigens, e.g. SSX, BAGE, GAGE or SAGE
- A61K39/001186—MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001184—Cancer testis antigens, e.g. SSX, BAGE, GAGE or SAGE
- A61K39/001188—NY-ESO
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001184—Cancer testis antigens, e.g. SSX, BAGE, GAGE or SAGE
- A61K39/001189—PRAME
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/00119—Melanoma antigens
- A61K39/001192—Glycoprotein 100 [Gp100]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5152—Tumor cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5156—Animal cells expressing foreign proteins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Developmental Biology & Embryology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33449101P | 2001-11-30 | 2001-11-30 | |
US60/334,491 | 2001-11-30 | ||
PCT/EP2002/013531 WO2003045428A2 (en) | 2001-11-30 | 2002-11-29 | Use of a technically modified cell as a vaccine for treating tumoral disease |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002356763A1 true AU2002356763A1 (en) | 2003-06-10 |
Family
ID=23307453
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002356763A Abandoned AU2002356763A1 (en) | 2001-11-30 | 2002-11-29 | Use of a technically modified cell as a vaccine for treating tumoral disease |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002356763A1 (en) |
WO (1) | WO2003045428A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7956043B2 (en) | 2002-12-11 | 2011-06-07 | Coley Pharmaceutical Group, Inc. | 5′ CpG nucleic acids and methods of use |
DE10362104B4 (en) * | 2003-08-29 | 2008-02-14 | Kist-Europe Forschungsgesellschaft Mbh | Cell processor for disease treatment |
RU2354694C2 (en) * | 2003-12-30 | 2009-05-10 | Мологен Аг | Allogeneic antitumor therapeutic medication |
CN103245787B (en) * | 2012-02-01 | 2016-01-20 | 浙江大学 | A kind of preparation method of liver cancer derivative growth factor detection kit |
EP3545001A4 (en) * | 2016-11-22 | 2020-10-21 | Alloplex Biotherapeutics | Allogenic tumor cell vaccine |
US11185586B2 (en) | 2016-11-22 | 2021-11-30 | Alloplex Biotherapeutics, Inc. | Allogeneic tumor cell vaccine |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0904786T3 (en) * | 1997-08-22 | 2005-03-21 | Science Park Raf S P A | Tumor vaccination using autologous or HLA-related antigen presenting cells (APC) transduced with a tumor antigen and a foreign antigen that may elicit an immune response |
-
2002
- 2002-11-29 WO PCT/EP2002/013531 patent/WO2003045428A2/en not_active Application Discontinuation
- 2002-11-29 AU AU2002356763A patent/AU2002356763A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2003045428A3 (en) | 2003-12-18 |
WO2003045428A2 (en) | 2003-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL159344A0 (en) | Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease | |
HUP0204250A3 (en) | Use of hiv-protein or -polynucleotide for vaccine produce | |
AU2001282873A1 (en) | Quinuclidine-substituted aryl compounds for treatment of disease | |
AU2003219690A1 (en) | Fused bicyclic-n-bridged-heteroaromatic carboxamides for the treatment of disease | |
AU2002257936A1 (en) | Methods of well treatment | |
AU2001227837A1 (en) | Novel treatment for eye disease | |
AU2001284646A1 (en) | Quinuclidine-substituted heteroaryl moieties for treatment of disease | |
AU2001282875A1 (en) | Quinuclidine-substituted heteroaryl moieties for treatment of disease | |
HUP0300099A3 (en) | Vaccine for the treatment of artherosclerosis | |
AU2001284645A1 (en) | Quinuclidine-substituted aryl compounds for treatment of disease | |
AU2002356763A1 (en) | Use of a technically modified cell as a vaccine for treating tumoral disease | |
AU2002335061A1 (en) | Hookworm vaccine | |
AU2003229346A1 (en) | Use of a vaccine for active immunization against cancer | |
GB0209254D0 (en) | Preparation for the relief of disease | |
AU2003298725A8 (en) | Preparation of metallotexaphyrins | |
GB0201025D0 (en) | The treatment of degenerative diseases | |
AU2003239773A1 (en) | Preparation of vaccines | |
AU2003213700A1 (en) | Immunogens for treatment of neoplastic and infectious disease | |
AU2001262520A1 (en) | Combined preparation for the treatment of neoplasic diseases | |
GB0100092D0 (en) | Treatment of degenerative diseases | |
EP1437347A3 (en) | Process for the preparation of arylvinyl halides and aralkinyl compounds | |
AU2002241776A1 (en) | Treatment of disease by inducing cell apoptosis | |
AU2003243215A1 (en) | Treatment for human papillomavirus | |
AU2002322013A1 (en) | Therapeutic dna vaccination | |
AU2002338794A1 (en) | Use of mannosamine derivatives for the stimulation of neurite growth |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |